a public good project by the
Synthesis
Company
of California

© 2026

Gabriela B. Thoennissen | doi.page

0 works0 citations0 h-index

Gabriela B. Thoennissen

Universität Hamburg(DE)University Medical Center Hamburg-Eppendorf(DE)University Cancer Center Hamburg(DE)

Publications by Year

Research Areas

Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Protein Degradation and Inhibitors, Immune Response and Inflammation

Most-Cited Works

→ BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint(2013)117 cited
→ Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis(2013)107 cited
→ C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice(2012)87 cited
→ The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer(2012)55 cited
→ Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil‐specific antibacterial clearance(2014)45 cited
→ Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma(2012)29 cited

→ Novel CUX1 missense mutation in association with 7q− at leukemic transformation of MPN(2011)

23 cited

→ DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center(2013)17 cited

→ Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis(2017)10 cited

→ Alveolar rhabdomyosarcoma confined to the bone marrow with no identifiable primary tumour using FDG-PET/CT(2015)9 cited